SCHEMBL5871726

SCHEMBL5871726

COc1ccc(C(OC(=O)C(=O)OC(c2ccc(OC)nc2)c2ccc3ccn(C4CCN(CCc5ccc(F)cc5)CC4)c3c2)c2ccc3ccn(C4CCN(CCc5ccc(F)cc5)CC4)c3c2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 4/20 0.40
HTR1B P28222 4/20 0.40
HTR1A P08908 2/20 0.40
HTR1F P30939 1/20 0.40
HTR2A P28223 9/20 0.39
HTR7 P34969 6/20 0.39
HTR2C P28335 6/20 0.39
HRH1 P35367 5/20 0.39
DRD1 P21728 4/20 0.39
ADRA1B P35368 4/20 0.39
HTR2B P41595 4/20 0.39
GRM2 Q14416 3/20 0.39
KCNH2 Q12809 3/20 0.39
DRD4 P21917 3/20 0.39
HRH2 P25021 3/20 0.39
SLC6A4 P31645 3/20 0.39
DRD2 P14416 3/20 0.39
ADRA2C P18825 2/20 0.39
DRD5 P21918 2/20 0.39
ADRA1A P35348 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872070 0.89 HTR2A (0.43) HTR1DHTR1BHTR1AHTR1FHTR2A
Oxalic Acid SCHEMBL5871722 0.89 HTR2A (0.40) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL5871629 0.84 HTR1A (0.46) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL5871704 0.84 HTR2A (0.46) HTR1DHTR1BHTR1AHTR1FHTR2A
Oxalic Acid SCHEMBL7224209 0.82 HTR1A (0.44) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL5872034 0.82 HTR2A (0.46) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL5871375 0.78 HTR2A (0.53) HTR1DHTR1BHTR1AHTR1FHTR2A
Oxalic Acid SCHEMBL5871700 0.78 HTR2A (0.49) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL6633578 0.77 HTR2A (0.46) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL5871956 0.76 HTR2A (0.56) HTR1DHTR1BHTR1AHTR1FHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071201-B2 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline EISAI CO., LTD. (JP) 2006-07-04 US disclosed
EP-0976732-B1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES EISAI CO LTD (JP) 2004-11-24 EP disclosed
US-6579881-B2 Indoles EISAI CO., LTD. (JP) 2003-06-17 US disclosed
US-6448243-B1 SEROTONIN ANTAGONIST FOR TREATING, AMELIORATING AND PREVENTING SPASTIC PARALYSIS OR CENTRAL MUSCLE RELAXANTS FOR AMELIORATING MYOTONIA EISAI CO., LTD. (JP) 2002-09-10 US disclosed
US-20020086999-A1 Certain quinoline derivatives EISAI CO., LTD. 2002-07-04 US disclosed
US-20020019531-A1 Indoles EISAI CO., LTD. 2002-02-14 US disclosed
EP-0976732-A1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019531-A1 Indoles INMT, MUSK, MB HTR1D 31/4885HTR1B 84/4885HTR1A 17/4885
US-20020086999-A1 Certain quinoline derivatives CHRM1, CHRNA5, CHRNA4 HTR1D 27/4885HTR1B 50/4885HTR1A 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.